全文获取类型
收费全文 | 18373篇 |
免费 | 1889篇 |
国内免费 | 204篇 |
专业分类
耳鼻咽喉 | 247篇 |
儿科学 | 363篇 |
妇产科学 | 778篇 |
基础医学 | 2722篇 |
口腔科学 | 368篇 |
临床医学 | 2207篇 |
内科学 | 2816篇 |
皮肤病学 | 1412篇 |
神经病学 | 733篇 |
特种医学 | 332篇 |
外国民族医学 | 1篇 |
外科学 | 1273篇 |
综合类 | 1246篇 |
现状与发展 | 1篇 |
一般理论 | 6篇 |
预防医学 | 2359篇 |
眼科学 | 132篇 |
药学 | 1342篇 |
8篇 | |
中国医学 | 125篇 |
肿瘤学 | 1995篇 |
出版年
2024年 | 8篇 |
2023年 | 386篇 |
2022年 | 488篇 |
2021年 | 909篇 |
2020年 | 1008篇 |
2019年 | 935篇 |
2018年 | 867篇 |
2017年 | 812篇 |
2016年 | 833篇 |
2015年 | 812篇 |
2014年 | 1254篇 |
2013年 | 1520篇 |
2012年 | 960篇 |
2011年 | 1115篇 |
2010年 | 852篇 |
2009年 | 843篇 |
2008年 | 743篇 |
2007年 | 728篇 |
2006年 | 659篇 |
2005年 | 491篇 |
2004年 | 455篇 |
2003年 | 394篇 |
2002年 | 338篇 |
2001年 | 288篇 |
2000年 | 258篇 |
1999年 | 264篇 |
1998年 | 216篇 |
1997年 | 200篇 |
1996年 | 198篇 |
1995年 | 190篇 |
1994年 | 176篇 |
1993年 | 147篇 |
1992年 | 171篇 |
1991年 | 125篇 |
1990年 | 108篇 |
1989年 | 118篇 |
1988年 | 104篇 |
1987年 | 85篇 |
1986年 | 53篇 |
1985年 | 79篇 |
1984年 | 66篇 |
1983年 | 41篇 |
1982年 | 32篇 |
1981年 | 33篇 |
1980年 | 31篇 |
1979年 | 20篇 |
1978年 | 9篇 |
1977年 | 13篇 |
1976年 | 18篇 |
1975年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
1.
2.
3.
4.
目的 探讨医院信息系统中增加住院陪护管理功能的应用效果。方法 基于互联网医院、智慧医院等信息系统,开发信息化住院陪护管理功能,包括流行病学史调查、免费核酸申请、电子陪护证办理、体温监测登记及上报和统计查询。该功能与医院智慧护理链接后全院应用。比较功能应用前和应用后的遵医嘱一患一陪达标率、有效陪护证达标率、体温监测并登记日上报达标率和陪护证使用追溯率,评价护士和管理者疫情防控管理的人均耗时以及对该管理功能的满意度。结果 应用信息化陪护管理功能后,一患一陪达标率、有效陪护证达标率、体温监测并登记日上报达标率和陪护证使用追溯率显著高于应用前(均P<0.05);护士陪护管理人均耗时从(554.13±30.77)s降至(311.67±21.54)s(P<0.05);护士和管理者对该信息化陪护管理功能的满意度显著提高(均P<0.05)。结论 信息化住院陪护管理功能的应用有效提升了疫情期间陪护的管理质量和管理效率,提高了一线护士和管理者的满意度。 相似文献
5.
目的:分析我院2020年1月1日至2020年9月中旬近4万余例女性HPV感染情况,为HPV疫苗接种、宫颈病变预防、治疗、随访提供流行病学数据。方法:选取我院2020年1月1日至2020年9月中旬之间,于我院妇科门诊及病房、皮肤科门诊及体检中心的37 325接受HPV分型检测的患者的临床资料,分析检测结果。结果:HPV感染率为13.91%(5 193/37 325),单一感染率11.46%(4 276/37 325),阳性构成比82.34%(4 276/5 193),高危亚型感染以HPV16最多见,其次52、58,低危型以6最多见,其次为11、44,与5年前HPV感染情况分析中最常见的低危亚型为cp8304不同。不同年龄段感染率不同。结论:近年沈阳地区妇女HPV感染率为13.91%,较5年前感染率18.60%有所下降,以单一、高危亚型感染为主,多重感染并存为特征。 相似文献
6.
Dissection of Capsid Protein HPV 52 to Rationalize Vaccine Designs Using Computational Approaches Immunoinformatics and Molecular Docking 下载免费PDF全文
Moh Egy Rahman Firdaus Apon Zaenal MustopaLita TriratnaGita SyahputraMaritsa Nurfatwa 《Asian Pacific journal of cancer prevention》2022,23(7):2243-2253
Background: Human Papillomavirus type 52 (HPV 52) is considered one of the threatening HPV types inducing cervical cancer worldwide. This study was conducted to address strategies of an effective vaccine against cervical cancer using computational approaches immuno-informatics and molecular docking. Methods: Major capsid protein L1 and L2 HPV 52 (L1 and L2 HPV 52) sequences were investigated by multiple analyses including B and T cell epitope, toxicity, allergenicity, Immunogenicity, epitope conservancy, population coverage, and molecular docking. Results: L1 and L2 HPV 52 showed a conserved sequence among amino acid levels. Q307K, S383D/N, and D473E are found as major mutations in L1, while mutations in L2 are S122T, Q247H, L247S, and E365D. Multiple epitopes were identified and elicited strong immune responses against cross types of HPV in various HLA populations. To enhance vaccine effectiveness that allows having cross-protection over HPV types, N terminus HPV L2 was analyzed suggesting multi-candidates chimeric L1/L2 vaccine design. Conclusion: This study shed a light on a useful pipeline with robust analysis for effective vaccine production. 相似文献
7.
8.
《Genetics in medicine》2022,24(9):1803-1813
PurposeGenes associated with nonsyndromic hearing loss are commonly included in reproductive carrier screening panels, which are now routinely offered in preconception and prenatal care in many countries. However, there is debate whether hearing loss should be considered a medical condition appropriate for screening. This systematic review assessed research on opinions of those with a lived experience of deafness and the general public regarding genetic testing for deafness in the reproductive setting.MethodsSearch of 5 online databases yielded 423 articles, 20 of which met inclusion criteria. We assessed the quality of each study, extracted data, and performed thematic analysis on qualitative studies.ResultsMost studies indicated interest in the use of prenatal diagnosis for deafness. However, there were mixed views, and sometimes strongly held views, expressed regarding the reproductive options that should be available to those with an increased chance of having a child with deafness. Studies were small, from a limited number of countries, and most were too old to include views regarding preimplantation genetic testing.ConclusionThere is a broad range of views regarding the use of reproductive options for deafness. Further research is essential to explore the benefits and harms of including nonsyndromic hearing loss genes in carrier screening. 相似文献
9.
Smita Joshi Richard Muwonge Vinay Kulkarni Mahesh Mandolkar Eric Lucas Sanjay Pujari Rengaswamy Sankaranarayanan Partha Basu 《International journal of cancer. Journal international du cancer》2023,152(2):249-258
We are reporting (a) updated incidence of cervical intraepithelial neoplasia (CIN) among women who did not have colposcopic or histopathological disease at baseline and (b) disease outcomes among women treated for CIN and their follow-up HPV status; in a cohort of women living with HIV (WHIV). The median overall follow-up was 3.5 years (IQR 2.8-4.3). The incidence of any CIN and that of CIN 2 or worse disease was 16.7 and 7.0 per 1000 person-years of observation (PYO), respectively. Compared with women who were HPV negative at baseline, women who cleared HPV infection had 23.95 times increased risk of incident CIN 2 or worse lesions (95% CI 2.40-661.07). Women with persistent HPV infection had 138.18 times increased risk of CIN 2 or worse lesions (95% CI 20.30-3300.22). Complete disease regression was observed in 65.6% of the HPV positive women with high-grade CIN and were treated with thermal ablation but HPV persistence was seen in 44.8% of those with high-grade disease. Among those who did not have any disease at baseline and were also HPV negative, about 87% (95% CI 83.79-89.48) women remained HPV negative during consecutive HPV test/s with the median interval of 3.5 years. Long-term surveillance of WHIV treated for any CIN is necessary for the prevention of cervical cancer among them. Our study provides an early indication that the currently recommended screening interval of 3 to 5 years among WHIV may be extended to at least 5 years among HPV negative women. Increasing the screening interval can be cost saving and improve scalability among WHIV to support WHO's cervical cancer elimination initiative. 相似文献
10.